Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Total Revenue $ 40,792 $ 27,185 $ 58,026 $ 33,563
Operating expenses        
Research and development (23,484) (24,034) (75,500) (62,240)
General and administrative (10,290) (8,111) (32,785) (22,284)
Total operating expenses (33,774) (32,145) (108,285) (84,524)
Operating income (loss) 7,018 (4,960) (50,259) (50,961)
Interest income 606 705 1,805 1,465
Other (expense) income, net (2,249) 3,602 (10,525) 7,242
Income (loss) before income taxes 5,375 (653) (58,979) (42,254)
Income taxes (133) (225) (362) (621)
Net income (loss) attributable to ordinary shareholders $ 5,242 $ (878) $ (59,341) $ (42,875)
Net income (loss) per ordinary share        
Basic (in dollars per share) $ 0.01   $ (0.10) $ (0.08)
Diluted (in dollars per share) $ 0.01   $ (0.10) $ (0.08)
Weighted average shares outstanding:        
Basic (in shares) 582,004,954 561,239,864 573,796,275 516,352,141
Diluted (in shares) 621,764,201 561,239,864 573,796,275 516,352,141
Development revenue        
Total Revenue $ 1,678 $ 27,185 $ 18,912 $ 33,563
License revenue        
Total Revenue $ 39,114   $ 39,114